NCT01098799

Brief Summary

The investigators are planning to study the serum level of Urotensin II in chronic kidney disease patients, kidney transplants, and healthy controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2010

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 2, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 5, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2010

Completed
Last Updated

June 13, 2013

Status Verified

June 1, 2013

Enrollment Period

3 months

First QC Date

April 2, 2010

Last Update Submit

June 12, 2013

Conditions

Chronic Renal Disease

Keywords

Urotensin II,Chronic renal disease

Outcome Measures

Primary Outcomes (1)

  • serum Urotensin II(UII)level

    We tried to compare UII level in normal, chronic kidney disease and kidney transplant patients group

    at enrollment

Study Arms (3)

Control

Healthy controls

Chronic kidney disease-1

Chronic kidney disease not taking dialysis treatment

Kidney Transplant

Kidney transplants

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy controls,CRF patients and kidney transplants aged more than 18

You may qualify if:

  • Age more than 18

You may not qualify if:

  • Inability to give a written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vakif Gureba Training & Research Hospital

Istanbul, 34100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Tufan Tukek, MD

    Vakif Gureba Training & Research Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chair

Study Record Dates

First Submitted

April 2, 2010

First Posted

April 5, 2010

Study Start

April 1, 2010

Primary Completion

July 1, 2010

Study Completion

July 1, 2010

Last Updated

June 13, 2013

Record last verified: 2013-06

Locations

TU(1)